Information about Alexofin
My details
*
*
*

Alexofin (SRL)

BE 0894.763.731

Dennenlei 24, 2900 Schoten

Company information

Status
Active

Enterprise number

BE0894.763.731

VAT liability
Yes
Established
04-01-2008
Last balance sheet year
2024
Company size
Small 0 FTE
Principal activity
Business and other management consultancy activities
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Alexofin

2024 2023 2022 2021
Profit/Loss € -78,019 59 % € -190,285 -165 % € 294,242 -63 % € 795,408
Equity € 1,128,719 -6 % € 1,206,738 -14 % € 1,397,024 27 % € 1,102,782
Gross margin € -73,588 60 % € -182,271 -143 % € 425,187 -66 % € 1,265,895

Publications from Alexofin

Date Publication
08-08-2025 Resignations - Appointments (NL)
09-02-2024 Modification(s) Articles of Association (NL)
28-03-2012 Resignations - Appointments (NL)
23-11-2009 Resignations - Appointments (NL)
11-09-2008 Registered Office (NL)

Frequently asked questions

What is the VAT number of Alexofin?
The VAT number of Alexofin is BE 0894.763.731.
Wat is the PEPPOL ID of Alexofin?
There is no information available about the PEPPOL ID of Alexofin or the company is not yet registered on the PEPPOL network.
When was Alexofin founded?
Alexofin was founded on 04-01-2008.
What is the address of Alexofin?
The current registered office of Alexofin is located at Dennenlei 24, 2900 Schoten.
When was the last time Alexofin filed their annual financial statements?
The most recent financial statements of Alexofin were filed on 02-09-2025.
How many employees does Alexofin have?
There are currently no employees working at Alexofin or no workforce information is available.
What is the annual turnover of Alexofin?
At the time of its most recent financial statements, Alexofin did not publish any turnover figures. Alexofin reported a gross margin of -€73,587.56.

Sources